Sotera Health upgraded by Wolfe Research with a new price target
$SHC
Misc Health and Biotechnology Services
Health Care
Wolfe Research upgraded Sotera Health from Peer Perform to Outperform and set a new price target of $25.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2025 | $17.00 | Neutral → Buy | Goldman |
| 12/6/2024 | $14.00 | Neutral | Goldman |
| 5/21/2024 | $13.00 | Neutral | Piper Sandler |
| 4/3/2024 | $18.00 → $16.00 | Neutral → Buy | Citigroup |
| 3/25/2024 | $15.00 → $15.50 | Hold → Buy | Jefferies |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/26/2023 | $24.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 1/23/2023 | $6.00 → $18.00 | Underweight → Neutral | JP Morgan |
4 - Sotera Health Co (0001822479) (Issuer)
4 - Sotera Health Co (0001822479) (Issuer)
4 - Sotera Health Co (0001822479) (Issuer)
SD - Sotera Health Co (0001822479) (Filer)
8-K - Sotera Health Co (0001822479) (Filer)
DEFA14A - Sotera Health Co (0001822479) (Filer)
Goldman upgraded Sotera Health from Neutral to Buy and set a new price target of $17.00
Goldman initiated coverage of Sotera Health with a rating of Neutral and set a new price target of $14.00
Piper Sandler initiated coverage of Sotera Health with a rating of Neutral and set a new price target of $13.00